209 related articles for article (PubMed ID: 17469181)
1. Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1.
Kidd M; Modlin IM; Pfragner R; Eick GN; Champaneria MC; Chan AK; Camp RL; Mane SM
Cancer; 2007 Jun; 109(12):2420-31. PubMed ID: 17469181
[TBL] [Abstract][Full Text] [Related]
2. Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor.
Zhang L; Sato E; Amagasaki K; Nakao A; Naganuma H
J Neurosurg; 2006 Jul; 105(1):119-28. PubMed ID: 16871886
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
4. The functional characterization of normal and neoplastic human enterochromaffin cells.
Modlin IM; Kidd M; Pfragner R; Eick GN; Champaneria MC
J Clin Endocrinol Metab; 2006 Jun; 91(6):2340-8. PubMed ID: 16537680
[TBL] [Abstract][Full Text] [Related]
5. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.
Claassen GF; Hann SR
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9498-503. PubMed ID: 10920185
[TBL] [Abstract][Full Text] [Related]
6. Suppression of c-Myc enhances p21
Jeong YJ; Hoe HS; Cho HJ; Park KK; Kim DD; Kim CH; Magae J; Kang DW; Lee SR; Chang YC
J Cell Biochem; 2018 Feb; 119(2):2036-2047. PubMed ID: 28833404
[TBL] [Abstract][Full Text] [Related]
7. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants.
Kidd M; Modlin IM; Gustafsson BI; Drozdov I; Hauso O; Pfragner R
Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G260-72. PubMed ID: 18556422
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1.
Yan Z; Kim GY; Deng X; Friedman E
J Biol Chem; 2002 Mar; 277(12):9870-9. PubMed ID: 11784716
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc-p21
Du S; Wang H; Cai J; Ren R; Zhang W; Wei W; Shen X
Biochem Cell Biol; 2020 Apr; 98(2):191-202. PubMed ID: 32167787
[TBL] [Abstract][Full Text] [Related]
10. MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines.
Salot S; Gude R
Eur J Cancer; 2013 Jan; 49(2):492-9. PubMed ID: 22841502
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes.
Baugé C; Legendre F; Leclercq S; Elissalde JM; Pujol JP; Galéra P; Boumédiene K
Arthritis Rheum; 2007 Sep; 56(9):3020-32. PubMed ID: 17763417
[TBL] [Abstract][Full Text] [Related]
13. The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia.
Kidd M; Modlin IM; Mane SM; Camp RL; Eick G; Latich I
Ann Surg Oncol; 2006 Feb; 13(2):253-62. PubMed ID: 16424981
[TBL] [Abstract][Full Text] [Related]
14. Synergistic role of c-Myc and ERK1/2 in the mitogenic response to TGF beta-1 in cultured rat nucleus pulposus cells.
Nakai T; Mochida J; Sakai D
Arthritis Res Ther; 2008; 10(6):R140. PubMed ID: 19061498
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein.
Zhang XY; DeSalle LM; Patel JH; Capobianco AJ; Yu D; Thomas-Tikhonenko A; McMahon SB
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13968-73. PubMed ID: 16172399
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice.
Yang W; Velcich A; Lozonschi I; Liang J; Nicholas C; Zhuang M; Bancroft L; Augenlicht LH
Am J Pathol; 2005 Apr; 166(4):1239-46. PubMed ID: 15793302
[TBL] [Abstract][Full Text] [Related]
17. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588
[TBL] [Abstract][Full Text] [Related]
18. [Effects of SB203580 and WP631 on Smad signal transduction pathway in lung fibroblasts after irradiation].
Li Y; Song LW; Peng RY; Wang DW; Jin MH; Gao YB; Ma JJ
Ai Zheng; 2008 Jul; 27(7):698-702. PubMed ID: 18606061
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
20. KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model.
Siddique ZL; Drozdov I; Floch J; Gustafsson BI; Stunes K; Pfragner R; Kidd M; Modlin IM
Neuroendocrinology; 2009; 89(4):458-70. PubMed ID: 19295186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
